Abstract:Although clinically approved hepatitis B virus (HBV) polymerase inhibitors (lamivudine-3TC, entecavir, etc.) serve as effective therapeutics, the virus can easily generate resistance to them. Therefore, the treatment of HBV infection remains a public health problem. Numerous studies have shown that natural products have prospective anti-HBV activity. The purpose of this study was to isolate and extract des(rhamnosyl) verbascoside from Lindernia ruellioides (Colsm.) Pennell and explore its anti-HBV and hepatoprotective effects. Anti-HBV activity was evaluated in HepG2.2.15 cells, a human hepatocellular carcinoma cell line with HBV-stable infection, and its protective effect was evaluated in HL-7702 cells, a normal human liver cell line. HepG2.2.15 cells maintained normal growth morphology within the selected concentration range of des(rhamnosyl) verbascoside. It also inhibited the expression of HBV antigens and HBV DNA in a dose- and time-dependent manner in vitro. Further, western blot experiments showed that it could downregulate HBV X protein (HBx) expression in a dose-dependent manner. In the H2O2-induced hepatocyte injury model, the cell-survival rate of the HL-7702 cells with the highest drug dose reached 85.25%, which was significantly improved compared with that of the model group. Most of the cells returned to normal morphology, showing polygonal or fusiform structures. Thus, it may be stated that des(rhamnosyl) verbascoside exhibits anti-HBV activity and hepatoprotective effects in vitro and may exert an anti-HBV effect via antigen inhibition, HBV DNA secretion, and HBx protein expression.

A hepatitis B virus inhibitory neolignan from Herpetospermum caudigerum.

ChemInform Abstract: A Hepatitis B Virus Inhibitory Neolignan from Herpetospermum Caudigerum.

Herpetin, a New Bioactive Lignan Isolated from Herpetospermum caudigerum

Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives As Novel Hepatitis B Virus Capsid Assembly Modulators

(−)-Lariciresinol Isolated from the Roots of Isatis indigotica Fortune ex Lindl. Inhibits Hepatitis B Virus by Regulating Viral Transcription

In Vitro Antiviral Activity of Three Enantiomeric Sesquiterpene Lactones from Senecio Species Against Hepatitis B Virus.

Chemical Constituents of Heracleum Dissectum and Their Cytotoxic Activity

Herpetosin A, a nor-cucurbitane triterpenoid with a 5/6/6/5 ring system from Herpetospermum pedunculosum

Junceellolide B, a Novel Inhibitor of Hepatitis B Virus.

New Lignans from the Leaves and Stems of Schisandra chinensis and Their Anti‐HIV‐1 Activities

Antiviral activities of Polygonum perfoliatum L. extract and related phenolic acid constituents against hepatitis B virus

Alkaloids from Corydalis Saxicola and Their Anti‐Hepatitis B Virus Activity

Evaluation of Antiviral Activity of Compounds Isolated from Ranunculus Sieboldii and Ranunculus Sceleratus

Anti‐hepatitis B virus activity and hepatoprotective effect of des(rhamnosyl) verbascoside from Lindernia ruellioides in vitro

Bioactive Flavones and Biflavones from Selaginella Moellendorffii Hieron.

A New Benzofuran Derivative Glycoside and a New Coumarin Glycoside from Roots of Heracleum Dissectum Ledeb

Two new lignans from Dipteronia dyeriana

Inhibitory activity against tobacco mosaic virus (TMV) replication of pinoresinol and syringaresinol lignans and their glycosides from the root of Rhus javanica var. roxburghiana.

Dimeric Matrine-Type Alkaloids from the Roots of Sophora Flavescens and Their Anti-Hepatitis B Virus Activities

H1-A, A Compound Isolated from Fusarium Oxysporum Inhibits Hepatitis C Virus (hcv) Ns3 Serine Protease

Schisanwilsonins A-G and Related Anti-Hbv Lignans from the Fruits of Schisandra Wilsoniana